Overview
The CREBtide [KRREILSRRPSYR], Phosphorylated, C-term K is an essential synthetic substrate for protein kinase A (PKA). Based on the phosphorylation sequence found in d-CREB, this peptide plays a crucial role in numerous biological processes influenced by cAMP signaling pathways. By incorporating this specialized peptide into your research, you can gain valuable insights into the mechanisms of protein phosphorylation and its impact on cellular activities.
Key Features
- High purity synthetic substrate for PKA
- Designed based on the phosphorylation sequence of d-CREB
- Km value of 3.9 µM, ensuring optimized performance
- Versatile applications in biochemistry and molecular biology
- A valuable tool for studying cAMP-related signaling pathways
Specifications
| Item | Details |
|---|---|
| Product Name | CREBtide [KRREILSRRPSYR], Phosphorylated, C-term K |
| Form | Peptide |
| Weight | 1 mg |
| Km Value | 3.9 µM |
FAQ
What are the main applications of CREBtide?
CREBtide is primarily used as a synthetic substrate for PKA research, allowing scientists to study phosphorylation dynamics within cells. Its design based on the d-CREB sequence makes it particularly valuable in understanding cAMP pathway regulation.
How should I store the CREBtide?
For optimal stability, store CREBtide at -20°C in a dry environment. Avoid repeated freeze-thaw cycles to maintain peptide integrity and performance.
Can I use CREBtide in combination with other substrates?
Yes, CREBtide can be effectively used alongside other substrates like PKG Substrate [RKRSRAE], Glasstide or Autocamtide-2 [KKALRRQETVDAL] to explore various aspects of kinase activity and signaling pathways.
Enhance your research today by purchasing CREBtide [KRREILSRRPSYR] from AnaSpec. It’s your go-to solution for investigating protein kinase A activities.
Related Products
Browse more in Peptides.



![CREBtide [KRREILSRRPSYR], Phosphorylated, C-term K - 1 mg](https://anaspecstore.com/wp-content/uploads/2026/10/as-27018-img-en-as-27018-01.jpg)
Reviews
There are no reviews yet.